Indocyanine Green Market

Indocyanine Green Market Size, Share & Industry Analysis, By Application (Medical Pharmaceutical, Scientific Research), Key End-Use Industry (Hospitals & Diagnostic Imaging Centers, Academic & Research Institutions, Pharmaceutical Formulation Manufacturers, Contract Development & Manufacturing Organizations (CDMOs)), and Forecast, 2025–2035

​The Indocyanine Green (ICG) market is projected to grow at a CAGR of 8.5% between 2025 and 2035. This growth is primarily driven by the increasing adoption of ICG in medical diagnostics, technological advancements in imaging techniques, and the rising prevalence of chronic diseases requiring precise diagnostic procedures. ​

Regionally, North America holds a significant share in the Indocyanine Green market, primarily due to the well-established healthcare infrastructure and high adoption rate of advanced diagnostic technologies. Europe follows closely, with increasing healthcare expenditure and a growing focus on early disease detection. The Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by the rising healthcare awareness, improving healthcare infrastructure, and increasing investments in medical research. ​

The market report emphasizes ongoing innovations in Indocyanine Green formulations, which are enhancing their efficacy and patient compliance. However, challenges such as rising competition from generic alternatives, pricing pressures, and regulatory hurdles may impact growth. Despite these challenges, the increasing need for effective diagnostic tools and advancements in Indocyanine Green-based therapies are expected to drive market expansion in the coming years.

Seeking Comprehensive Intelligence on Different markets? Get in Touch with our Experts

Report Scope & Segmentation

  1. Introduction
  • Overview of Indocyanine Green
  • Key Applications & Industry Use Cases
  • Market Scope & Study Objectives
  1. Market Overview
  • Global Market Size & Growth Trends (Historical & Forecast)
  • Market Value & Revenue Analysis
  • Demand-Supply Dynamics
  1. Segmental Outlook
  • By Application
    • Medical Pharmaceutical
    • Scientific Research
  • Key End-User Industry
    • Hospitals & Diagnostic Imaging Centers
    • Academic & Research Institutions
    • Pharmaceutical Formulation Manufacturers
    • Contract Development & Manufacturing Organizations (CDMOs)

 

  1. Price Analysis
  • Current Price Trends (Per kg & Per Ton)
  • Price Fluctuation Factors (Raw Material Costs, Production, Trade Tariffs)
  • Regional Price Comparison (North America, Europe, Asia-Pacific, and Other)
  1. Production & Supply Volume
  • Global Production Capacity & Key Manufacturers
  • Production Process & Technological Developments
  • Raw Material Analysis
  1. Trade Analysis (Import & Export)
  • Major Exporting & Importing Countries
  • Trade Volume & Value Statistics
  • Impact of Trade Regulations & Policies
  1. Regional Analysis
  • North America (US and Canada)
  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, Taiwan, India, and Rest of Asia-Pacific)
  • Rest of the World (Latin America and Middle East and Africa)
  1. Competitive Landscape
  • Top Global Manufacturers & Market Share
  • Company Profiles & Key Developments
  • Mergers, Acquisitions & Investments
  1. Regulatory & Compliance Factors
  • FDA, REACH, and Other Regulatory Frameworks
  • Environmental & Safety Considerations
  • Emerging Policies Impacting Market Growth
  1. Conclusion & Strategic Recommendations
  • Key Takeaways for Stakeholders
  • Market Entry Strategies

 

What is Indocyanine Green?
Indocyanine Green (ICG) is an active pharmaceutical ingredient and a water-soluble, tricarbocyanine dye used extensively in medical diagnostics. It is primarily utilized for imaging applications, including liver function tests, cardiac output measurements, and ophthalmic angiography.
What is the market size for Indocyanine Green API?
The global Indocyanine Green API market is growing at a CAGR of 8.5% during the forecast period, driven by the rising demand for advanced diagnostic imaging techniques and minimally invasive surgeries is driving this market expansion.
What are the drivers for the Indocyanine Green market?
Key drivers include the increasing adoption of ICG in medical diagnostics, technological advancements in imaging techniques, and the rising prevalence of chronic diseases requiring precise diagnostic procedures.
Who are the key players operating in the Indocyanine Green market?
Major players in the Indocyanine Green market include Akorn, PULSION Medical Systems AG, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical Co., Ltd., Aurolab, Yichuang, and Eisai.
Which region is expected to exhibit the fastest growth in the Indocyanine Green market?
The Asia-Pacific region is exhibit to experience the highest growth in the Indocyanine Green market. This growth is attributed to increasing healthcare access, rising prevalence of chronic diseases, and expanding pharmaceutical manufacturing capabilities in countries like China and India.
$1800/- Single User License
$3600/- Multi User License

How can we help you?

Reach out to discuss how our team can help your business achieve real results.